Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Bioenerg Biomembr ; 48(4): 437-49, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27222029

RESUMEN

Trypanosoma cruzi, the aetiological agent of Chagas's disease, metabolizes glucose, and after its exhaustion, degrades amino acids as energy source. Here, we investigate histidine uptake and its participation in energy metabolism. No putative genes for the histidine biosynthetic pathway have been identified in genome databases of T. cruzi, suggesting that its uptake from extracellular medium is a requirement for the viability of the parasite. From this assumption, we characterized the uptake of histidine in T. cruzi, showing that this amino acid is incorporated through a single and saturable active system. We also show that histidine can be completely oxidised to CO2. This finding, together with the fact that genes encoding the putative enzymes for the histidine - glutamate degradation pathway were annotated, led us to infer its participation in the energy metabolism of the parasite. Here, we show that His is capable of restoring cell viability after long-term starvation. We confirm that as an energy source, His provides electrons to the electron transport chain, maintaining mitochondrial inner membrane potential and O2 consumption in a very efficient manner. Additionally, ATP biosynthesis from oxidative phosphorylation was found when His was the only oxidisable metabolite present, showing that this amino acid is involved in bioenergetics and parasite persistence within its invertebrate host.


Asunto(s)
Adenosina Trifosfato/biosíntesis , Histidina/metabolismo , Trypanosoma cruzi/metabolismo , Transporte Biológico Activo , Transporte de Electrón , Metabolismo Energético , Histidina/fisiología , Fosforilación Oxidativa , Proteínas Protozoarias/metabolismo
2.
Rev cuba genet comunit ; 5(1)ene.-abr. 2011. ilus, tab
Artículo en Español | CUMED | ID: cum-47101

RESUMEN

La Histidinemia es una enfermedad metabólica hereditaria rara, caracterizada por una deficiencia de la enzima histidasa, que ocasiona un aumento de las concentraciones de Histidina en sangre, orina y en líquido cefalorraquídeo y en ocasiones hiperalaninemia. Su cuadro clínico varía desde la presencia de retraso mental y un defecto del habla hasta la ausencia de manifestaciones. El diagnóstico de la enfermedad requiere de la aplicación de pruebas basadas en la cuantificación de L-Histidina en sangre. Se determinaron los niveles de Histidina en sangre seca neonatal a 348 muestras, con el propósito de establecer el intervalo de referencia en el laboratorio de este aminoácido. La cuantificación de las muestras se realizó empleando un método ultramicroanalítico, previamente validado en nuestro laboratorio para la cuantificación de Histidina en sangre. El intervalo de referencia en el laboratorio de histidina en sangre seca neonatal, para un 95 por ciento de probabilidad, fue de 4,59-16,74 mg/dL (296-1079 µM)(AU)


Histidinemia is a rare inherited metabolic disorder characterized by deficient histidase enzyme, which results in elevated histidine levels in blood, urine and cerebrospinal fluid and, sometimes, hyperalaninemia. Histidinemia clinical picture varies from mental retardation and speech disorders to absence of any symptoms. This disease can be diagnosed by histidine-level-in-blood-quantitating tests. In the following work the levels of Histidina were determined in neonatal dry blood to 348 samples in order to establish the reference intervals in the laboratory of this amino acid. The quantification of the samples was carried out using an ultra micro analytic method, previously validated in our laboratory for the quantification of Histidina in blood. The obtained reference interval (95 percent probability) in the laboratory was of 4, 59 -16, 74 mg/dL (296-1079 µM)(AU)


Asunto(s)
Histidina/fisiología , Histidina Amoníaco-Liasa/deficiencia , Valores de Referencia , Errores Innatos del Metabolismo
3.
J Bacteriol ; 188(9): 3324-8, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16621826

RESUMEN

Escherichia coli microcin J25 (MccJ25) is a plasmid-encoded antibiotic peptide consisting of 21 L-amino acid residues (G1-G-A-G-H5-V-P-E-Y-F10-V-G-I-G-T15-P-I-S-F-Y20-G). E. coli RNA polymerase (RNAP) is the intracellular target of MccJ25. MccJ25 enters cells after binding to specific membrane transporters: FhuA in the outer membrane and SbmA in the inner membrane. Here, we studied MccJ25 mutants carrying a substitution of His5 by Lys, Arg, or Ala. The inhibitory effects on cellular growth and in vitro RNAP activity were determined for each mutant microcin. The results show that all mutants inhibited RNAP in vitro. However, the mutants were defective in their ability to inhibit cellular growth. Experiments in which the FhuA protein was bypassed showed that substitutions of MccJ25 His5 affected the SbmA-dependent transport. Our results thus suggest that MccJ25 His5 located in the lariat ring is involved, directly or indirectly, in specific interaction with SbmA and is not required for MccJ25 inhibition of RNAP.


Asunto(s)
Antibacterianos/metabolismo , Bacteriocinas/metabolismo , Proteínas de Escherichia coli/metabolismo , Escherichia coli/metabolismo , Histidina/fisiología , Proteínas de la Membrana/metabolismo , Sustitución de Aminoácidos , Antibacterianos/farmacología , Bacteriocinas/genética , Bacteriocinas/farmacología , Transporte Biológico , ARN Polimerasas Dirigidas por ADN/antagonistas & inhibidores , ARN Polimerasas Dirigidas por ADN/metabolismo , Escherichia coli/efectos de los fármacos , Escherichia coli/crecimiento & desarrollo , Histidina/genética , Mutación , ARN Bacteriano/biosíntesis
4.
J Biol Chem ; 280(36): 31949-56, 2005 Sep 09.
Artículo en Inglés | MEDLINE | ID: mdl-16027123

RESUMEN

The biological activity of granulocyte-macrophage colony-stimulating factor (GM-CSF) is modulated by the sulfated glycosaminoglycans (GAGs) heparan sulfate and heparin. However, the molecular mechanisms involved in such interactions are still not completely understood. We have proposed previously that helix C, one of the four alpha-helices of human GM-CSF (hGM-CSF), contains a GAG-binding site in which positively charged residues are spatially positioned for interaction with the sulfate moieties of the GAGs (Wettreich, A., Sebollela, A., Carvalho, M. A., Azevedo, S. P., Borojevic, R., Ferreira, S. T., and Coelho-Sampaio, T. (1999) J. Biol. Chem. 274, 31468-31475). Protonation of two histidine residues (His83 and His87) in helix C of hGM-CSF appears to act as a pH-dependent molecular switch to control the interaction with GAGs. Based on these findings, we have now generated a triple mutant form of murine GM-CSF (mGM-CSF) in which three noncharged residues in helix C of the murine factor (Tyr83, Gln85, and Tyr87) were replaced by the corresponding basic residues present in hGM-CSF (His83, Lys85, and His87). Binding assays on heparin-Sepharose showed that, at acidic pH, the triple mutant mGM-CSF binds to immobilized heparin with significantly higher affinity than wild type (WT) mGM-CSF and that neither protein binds to the column at neutral pH. The fact that even WT mGM-CSF binds to heparin at acidic pH indicates the existence of a distinct, lower affinity heparin-binding site in the protein. Chemical modification of the single histidine residue (His15) located in helix A of WT mGM-CSF with diethyl pyrocarbonate totally abolished binding to immobilized heparin. Moreover, replacement of His15 for an alanine residue significantly reduced the affinity of mGM-CSF for heparin at pH 5.0 and completely blocked heparin binding to a synthetic peptide corresponding to helix A of GM-CSF. These results indicate a major role of histidine residues in the regulation of the binding of GM-CSF to GAGs, supporting the notion that an acidic microenvironment is required for GM-CSF-dependent regulation of target cells. In addition, our results provide insight into the molecular basis of the strict species specificity of the biological activity of GM-CSF.


Asunto(s)
Factor Estimulante de Colonias de Granulocitos y Macrófagos/química , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Heparina/metabolismo , Histidina/fisiología , Secuencia de Aminoácidos , Animales , Sitios de Unión , Factor Estimulante de Colonias de Granulocitos y Macrófagos/genética , Heparitina Sulfato/metabolismo , Histidina/metabolismo , Humanos , Ratones , Datos de Secuencia Molecular , Mutación , Péptidos/metabolismo , Fosforilcolina/análogos & derivados , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Especificidad de la Especie
5.
Braz J Med Biol Res ; 38(6): 813-23, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15933774

RESUMEN

Enveloped viruses always gain entry into the cytoplasm by fusion of their lipid envelope with a cell membrane. Some enveloped viruses fuse directly with the host cell plasma membrane after virus binding to the cell receptor. Other enveloped viruses enter the cells by the endocytic pathway, and fusion depends on the acidification of the endosomal compartment. In both cases, virus-induced membrane fusion is triggered by conformational changes in viral envelope glycoproteins. Two different classes of viral fusion proteins have been described on the basis of their molecular architecture. Several structural data permitted the elucidation of the mechanisms of membrane fusion mediated by class I and class II fusion proteins. In this article, we review a number of results obtained by our laboratory and by others that suggest that the mechanisms involved in rhabdovirus fusion are different from those used by the two well-studied classes of viral glycoproteins. We focus our discussion on the electrostatic nature of virus binding and interaction with membranes, especially through phosphatidylserine, and on the reversibility of the conformational changes of the rhabdovirus glycoprotein involved in fusion. Taken together, these data suggest the existence of a third class of fusion proteins and support the idea that new insights should emerge from studies of membrane fusion mediated by the G protein of rhabdoviruses. In particular, the elucidation of the three-dimensional structure of the G protein or even of the fusion peptide at different pH's might provide valuable information for understanding the fusion mechanism of this new class of fusion proteins.


Asunto(s)
Glicoproteínas/fisiología , Fusión de Membrana/fisiología , Rhabdoviridae/fisiología , Proteínas Virales de Fusión/fisiología , Animales , Proteínas de Unión al GTP/fisiología , Histidina/fisiología , Humanos , Glicoproteínas de Membrana/fisiología , Fosfatidilserinas/fisiología
6.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;38(6): 813-823, June 2005. ilus, tab
Artículo en Inglés | LILACS | ID: lil-402669

RESUMEN

Enveloped viruses always gain entry into the cytoplasm by fusion of their lipid envelope with a cell membrane. Some enveloped viruses fuse directly with the host cell plasma membrane after virus binding to the cell receptor. Other enveloped viruses enter the cells by the endocytic pathway, and fusion depends on the acidification of the endosomal compartment. In both cases, virus-induced membrane fusion is triggered by conformational changes in viral envelope glycoproteins. Two different classes of viral fusion proteins have been described on the basis of their molecular architecture. Several structural data permitted the elucidation of the mechanisms of membrane fusion mediated by class I and class II fusion proteins. In this article, we review a number of results obtained by our laboratory and by others that suggest that the mechanisms involved in rhabdovirus fusion are different from those used by the two well-studied classes of viral glycoproteins. We focus our discussion on the electrostatic nature of virus binding and interaction with membranes, especially through phosphatidylserine, and on the reversibility of the conformational changes of the rhabdovirus glycoprotein involved in fusion. Taken together, these data suggest the existence of a third class of fusion proteins and support the idea that new insights should emerge from studies of membrane fusion mediated by the G protein of rhabdoviruses. In particular, the elucidation of the three-dimensional structure of the G protein or even of the fusion peptide at different pH's might provide valuable information for understanding the fusion mechanism of this new class of fusion proteins.


Asunto(s)
Animales , Humanos , Glicoproteínas/fisiología , Fusión de Membrana/fisiología , Rhabdoviridae/fisiología , Proteínas Virales de Fusión/fisiología , Proteínas de Unión al GTP/fisiología , Histidina/fisiología , Glicoproteínas de Membrana/fisiología , Fosfatidilserinas/fisiología
7.
In. Suardiaz, Jorge; Cruz, Celso; Colina, Ariel. Laboratorio Clínico. La Habana, Ecimed, 2004. , graf.
Monografía en Español | CUMED | ID: cum-50547
8.
Arch Latinoam Nutr ; 28(2): 143-51, 1978 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-380490

RESUMEN

Recent experimental observations as well as theoretical considerations suggest that histidine may be an essential amino acid for the adult man. In this paper, an up-to-date review of the literature on the essentiality of histidine is presented. Some practical implications of the indispensability of this amino acid in the human diet are also discussed.


Asunto(s)
Dieta , Histidina/fisiología , Fenómenos Fisiológicos de la Nutrición , Necesidades Nutricionales , Adulto , Histidina/análisis , Histidina/metabolismo , Humanos , Verduras/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA